Indonesian Journal of Cancer
Vol 13, No 2 (2019): June

Survival Analysis in Pediatric Osteosarcoma

Mururul Aisyi (Pediatric Hematology Oncology Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Ayu Hutami Syarif (Research and Development Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Nur Asih Anggraeni (Research and Development Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Adhitya Bayu Perdana (Research and Development Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Hutomo Rezky (General Medicine Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Agus Kosasih (Clinical Pathology Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)
Achmad Basuki (Orthopedic Surgery Department, National Cancer Center-Dharmais Cancer Hospital, Jakarta)



Article Info

Publish Date
13 Jul 2019

Abstract

Background: Osteosarcoma is the most common bone malignancy in childhood and adolescence. Despite significant advances in diagnostic and therapeutic modalities, osteosarcoma has generally poor prognosis. Several studies highlighted the prognostic significance of demographic and clinical parameters in the pediatric population. Controversy exists about which obvious factors of mortality in some institutions. Meanwhile, little is known about the overall survival (OS) of pediatric osteosarcoma in Dharmais Cancer Hospital.The aim of this study is to estimate the OS in pediatric osteosarcoma.Methods: This retrospective cohort study enrolled 41 children with osteosarcoma during the period of January 2010-September 2017. Patients were selected using inclusion and exclusion criteria. Overall survival (OS) and patient variables were plotted using Kaplan-Meier.Results: Our result showed that all patients admitted to our hospital in advanced stages (IIB and III). Their median OS was 23 months (12.3-33.7 months) with the survival probability was 29.4%.Conclusions: Median OS of pediatric osteosarcoma in our institution was 23 months and the survival probability was 29.4%. It can be used as evidence showing lack of cancer awareness and early detection in our country.

Copyrights © 2019






Journal Info

Abbrev

ijoc

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health

Description

Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical ...